AMIA is pleased to invite submissions for the 2015 Summit on Translational Bioinformatics (TBI), to be held March 23-25, 2015, at the Parc 55 Hotel in San Francisco. The Summit will be part of the Joint Summits on Translational Science and will be immediately followed by the Summit on Clinical Research Informatics (CRI) at the same venue March 25-27.
Through tutorials, lectures, panels and posters, the 2015 TBI Summit will showcase the latest advances in bioinformatics methodology, discovery, and, increasingly, in actual clinical care through applications of personalized medicine. As in previous years, TBI and CRI will have joint programming on Wednesday, March 25. There will be an invigorated effort to integrate the CRI and TBI aspects for the Joint Summits this year and a special call for submissions that have relevance to both CRI and TBI communities.
With an emphasis on cutting edge and late breaking developments, we anticipate that the TBI Summit will continue to be the premier venue for showcasing the latest bioinformatics research at the dynamic interface of biomedical research and patient care. We look forward to your submissions and to a rich program of cutting-edge, innovative approaches in the field of Translational Bioinformatics.
Submission Deadline: September 25, 2014, 11:59 p.m. EDT
All submissions must be made through the submission site.
- Abstract Submission (Podium or Poster)
- Design Challenge – NEW
- Didactic Panel
- Interactive Panel – NEW
- Peer-based Learning Workshop – NEW
- Pre-Meeting Tutorial
Opportunities for Students
- Student Paper (sub-type of Paper)
- Design Challenge
After participating in the AMIA 2015 Summit on Translational Bioinformatics, learners should be better able to:
- Describe state-of-the-art informatics approaches, theories, and methods relevant to clinical and translational science
- Apply the latest findings from research and development of informatics applications that support clinical and translational biomedical research
- Consider possible frameworks for deploying and assessing clinical research informatics initiatives
- Interact with professionals engaged in clinical and translational science including clinical and translational investigators, data scientists, computational biologists, genomics researchers, statistical geneticists, clinical informaticians, public health informaticians, and those involved with clinical and research IT policy and regulatory issues
- Explore research-related initiatives emerging from national and international clinical and translational research informatics initiatives
- Biomedical and health informatics researchers and faculty
- Bioinformaticians, statistical geneticists, molecular biologists, and physician-scientists with interest in omic data
- Clinical and Translational Science Award (CTSA) researchers
- Computer scientists and system developers
- Computational biologists with interests in human disease, drug discovery, drug repurposing, and drug response
- Genome science ethicists, lawyers, and policy experts
- Government officials and policy makers
- Health information and knowledge management professionals
- HIT industry professionals and consultants
- Industry representatives related to bioinformatics and genomics
- Physicians, nurses, dentists, pharmacists, and other clinicians
- Public health informaticians/practitioners, patient advocates, consumer advocates, and disease management specialists
- Standards developers, with particular emphasis on EHR data repurposing or integration of omic data into EHRs